Renata Insight
ISS UE
09
JU LY 2019
OUR DEEPEST
CONDOLENCES
We are deeply saddened by the passing
away of our Director, Sales Pharma, Mr.
Khalil Musaddeq, on July 19, 2019 and
our Head of IT, Mr. Kazi Shibbir
Ahammed, on January 16, 2019.
From his early career Mr. Musaddeq has
been the heart and soul of Renata. Mr.
Musaddeq was a man who understood
business and company impeccably. His
business-friendly strategies have
immensely contributed to the growth
and development of Renata.
Mr. Musaddeq joined Renata in 1986 and
has been one of the crucial members of
Renata for last 33 years. Besides his role
at Renata, he has also worked as a
Director of Renata Agro Industries
Limited & Purnava Limited.
Mr. Ahammed has been instrumental in
developing in-house software and
introducing automation across various
operations. He along with his team were
responsible for spearheading the Oracle
ERP project.
Mr. Ahammed joined Renata in 1995 and
since then has been one of the crucial
members of IT team. Besides his role at
Renata, he has also worked as the In-
Charge of IT in Sajida Foundation from
1999 to 2005 and as an advisor for the
same in 2006.
Both of them was visionary, always
thinking ahead of others. Their touch in
various business operations is distinctly
visible. They have created a strong
infrastructure and has left Renata with
uncountable opportunities to work on.
Renata is truly grateful to them for all
their contributions and will miss them in
every step of the way.
BI- YEARLY
HR JOURNAL
A handful of companies dominate pharma market P.1
A handful of companies dominate pharma market
More than 68 per cent of the local pharmaceutical market is now being
dominated by only 10 companies, although a total of 204 are
registered with the authority concerned, industry people said. The size
of local pharmaceutical market stood at Tk 205.12 billion in 2018. The
industry recorded a 16.51 per cent growth between 2014 and 2018,
they added.
Only five companies hold 46.66 per cent of the market share, Square
Pharmaceuticals officials said citing IQVIA data.
IQVIA Inc, formerly known as Quintiles and IMS Health, is one the
world's largest contract research organisations. It is an American
multinational product-based company, serving the combined
industries of health information technologies and clinical research.
Square accounted for the highest 16.95 per cent market share. It is
followed by Incepta Pharma with 11.08 per cent market share,
Beximco with 8.26 per cent, Renata with 5.20 per cent, and Healthcare
Pharma 5.17 per cent. Of the other top companies, Opsonin Pharma
holds 5.08 per cent market share, ACI 4.38 per cent, Eskayef 4.37 per
cent, Aristopharma 4.11 per cent, and Acme holds 3.52 per cent share,
according to IQVIA data.
When asked, Square Pharmaceuticals Ltd Managing Director Tapan
Chowdhury said the country's top pharmaceuticals are developing the
necessary infrastructures as well as practices to align themselves with
global quality standards. "The top 10 companies are much inclined to
adopting modern technologies and maintaining excellence in their
manufacturing and marketing. Therefore, around 70 per cent of the
market share is enjoyed by these companies," he told the FE.
The financial strength of these companies also gives them scopes to adopt
modern technologies promptly. Moreover, the top 10 companies are
covering the maximum therapeutic classes, and it also ensures their certain
revenue generation and growth. The companies that are trying to adhere
to global quality standards are attaining manufacturing and marketing
excellence day by day.
PE OPLE & COMMUNICA TION
In This issue
MSDP P.2
In the world of reproductive healthcare P.3
Ten threats to global health in 2019 P.4
The market situation will be better with healthy growth, if more
companies enjoy larger market share, and the industry is gradually
moving towards that end. Directorate General of Drug Administration
(DGDA) is trying its level best to ensure that all companies maintain
quality. Quality can never be compromised for pharmaceuticals
industry. Besides, aligning with global regulatory standards will open
the door for the Bangladeshi companies to enter into the competitive
global market, he opined.
Terming the market dominance by the top 10 companies 'not a big
concentration', Centre for Policy Dialogue (CPD) Distinguished Fellow
Prof Mustafizur Rahman said the companies are in the business from
the very beginning, both in the local and foreign markets.
The focus now should be on how the small and medium-sized
companies can be scaled up, he said, suggesting measures to identify
and address the particular difficulties that they might face.
Medicines for acidity under the therapeutic class of anti-ulcerants have
become the major revenue driver for the local pharmaceutical industry
in the country. Drugs worth Tk 30.13 billion under this class were sold
last calendar year, according to IQVIA data. The other top-selling
medicines are - antibiotic, diabetic (insulin), calcium for bone and joint
pain, pain killer, nervous system, fever and paracetamol, diabetic
(oral), allergy and asthma, according to data.
Industry leaders said the government's policy support, doctors'
confidence, and trust of customers and people have helped the
industry to flourish over the decades. The local companies now meet
98 per cent of the local demand, and import of finished
pharmaceuticals is very low, they added.
Being a least developed country (LDC), Bangladesh enjoys waiver from
the TRIPS (Trade-Related Aspects of Intellectual Property Rights)
obligations. However, there are some concerns over continuation of
the preferential treatment under the agreement once the country
graduates to a middle-income one.
The industry leaders identified absence of sufficient knowledge,
training and exposure to global regulatory standards as the major
challenges for local pharmaceutical sector.
The government should provide flexible provisions for importing active
pharmaceutical ingredients (APIs), equipment and machinery for the
sector. Besides, industry-friendly policies should be taken after proper
evaluation to facilitate its investment outside the country, they added.
Source: Financial Express, February 6, 2019
EDITORIAL
Some emotionally rough times have been
faced by Renata Limited with the loss of
two of our dear leaders this year. Mr. Kazi
Shibbir Ahammed the Head of IT and Mr.
Khalil Musaddeq, Director, Sales Pharma.
Both the losses have been felt deeply
throughout Renata Limited and their
memories will be cherished by all. Death is
inevitable. However, when we lose those
near and dear to us the toll cannot be
expressed in words. We hope to move into
the future remembering our two dear
leaders and holding them close to our
hearts.
On the other hand, this year has been quite
eventful in some other ways too, for
instance, the “EMPRESS” HR system being
used for the employees review process for
the first time successfully, unique new
products have been launched in the market
by Purnava and Renata, registering Renata
in Europe in order to access the EU market
etc. Renata continues to encourage
employees to strive for big dreams and will
support them along the way. May this year
end on a good note for us all. Eid Mubarak
in advance!
NEWCOMERS
Renata strengthened manpower in the first
half of 2019. (Jan 2019 - Jun 2019)
Area of Operation No’s
Sales Pharma 140
Animal Health 45
Manufacturing 19
Distribution 09
Quality Assurance 43
R&D 07
Operations 24
Purnava Limited 12
SAD DEMISE
We are deeply sad to share the news that between
first half of 2019, we have lost the following
Renata family Members: Mr. Kazi Shibbir
Ahammed, Head of IT; Mr. Md. Raisul Islam,
Officer & Mr. Md. Abdul Mannan, Junior Officer,
Rangpur Depot. Let us all pray for the eternal
repose of the departed soul and for the bereaved
family. May they find the strength to carry on in
their time of sorrow.
Life @ RENATA
MSDP
Renata Limited is constantly harnessing its employees’ individual
personalities, goals, needs and abilities to build a successful and
intuitive working environment. Aligned with that perspective, Renata
Human Resources Division introduced a new development program
for the District Sales Managers and Senior District Sales Managers of
its Sales Pharma Division, Animal Health Division and Purnava Limited
named “MSDP – Managerial Skill Development program”. The
program will be covered throughout Bangladesh with a series of
follow ups. Already we covered our Rajshahi & Bogura Zone [Rajshahi,
Bogura, Rajshahi (AHD) & Bogura (AHD) Region], Dhaka Zone [Dhaka-
A, Dhaka-B, Dhaka-C, Dhaka-D, Dhaka-E, Dhaka-F, Narayaongonj &
Long Service Award
Dhaka (AHD) Region], Sylhet & Bhairab Zone [Bhairab, Bhairab (AHD), The Long Service Award (LSA) is presented to the employees of Renata Limited
Sylhet & Moulvibazar Region]. Ms. Nisbat Anwar, Head of HR in recognition of their long period of engagement with the organization. This
facilitated the program. award is presented to the employees who have completed at least 5 (Five)
years of continuous service. This is a matter of pride for those employees who
are serving long periods at Renata. This year employees of Renata HR visited
19 depots across the country to present this award to our field force and depot
colleagues. A total of 655 employees have been awarded with the Long Service
Award this year.
Balance for better
This year Renata Limited celebrated International Women’s
Collaboration with Marie stopes
Day associated with the campaign theme Renata Limited has started working jointly in conjunction
with Marie Stopes International to bring new initiatives
of #BalanceforBetter. A part of the celebration consisted of
a talk session which was arranged in the midst of nature at
in reproductive health and maternal health care in
Bangladesh. In this regard Marie Stopes Bangladesh and
the scenic Renata Park. Professor Dr. Mehtab Khanam was
Renata Limited have signed an agreement to implement
the Chief guest who is a renowned personality in the such initiative at the Marie Stopes International office in
mental health sector and also known for her solid presence Dhaka.
in any event and as a strong voice for women of
Under the agreement, Marie Stopes is going to introduce
Bangladesh. With this year’s theme of Balance in mind, the
medicine called 'Mariepriest'. Renata Limited will be
talk session emphasized on how to maintain balance amidst producing the medicine. The Country Director of Marie
the daily stress of life irrespective of gender. Despite the Stopes Bangladesh Mr. Masrurul Islam and Mr. Kamrul
program being Women’s day celebration, a good number Hasan Kenedy, General Manager, International &
of male colleagues’ participation reflected Renata’s
Institutional Business of Renata Limited signed the
agreement in this regard.
balanced culture.

In to the world of The Reproductive Health Care
Mr. Mr. Shams-Ud-Dowla, Assistant Manager, International Business Division
With the advancement of medical
science, one of the key health issues that
has been brought into the lime light is the
reproductive health care system. The
ongoing shout out for family planning, the
diversified social structure, growing
significance of women’s health care and
gender equality have been the key points
here.
Globally, 62 percent of married women
between the ages of 15 to 49 use a
method of family planning and 56 percent
use a modern method. Examples of
modern methods include the
intrauterine devices, implants,
injectables, condoms, and sterilization.
These rates are twice as high among
women living in high-income countries
(67 percent and 60 percent, respectively)
compared to women living in low-income
countries (34 percent and 29 percent,
respectively)—a result of differences in
access to, availability of, and demand for
modern methods of contraception. At a
country level, use of any method of family
planning among married women can vary
significantly, ranging from 4 percent
Did You
Know??
Renata (Ireland)
Limited
Renata Limited has
recently has formed a new
subsidiary namely Renata
(Ireland) Limited. Renata
(Ireland) has been set
merely as part of the
regulatory process. We
hope that in coming days
this will work as one of the
important hubs for our
future exports to the
European markets.
(South Sudan) to 88 percent (Norway). Services International and notably DKT
Source: PRB. International has been our major route to
What are the current key points upon the global market. Our product reached the
which there is a global concern and low economic regions as well as
ongoing activities focused on? economically established ones. We are
- Substantial differences in modern focused not only on introducing our brands
contraceptive use are evident globally but to manufacture other brands
across countries for the global giants. One of the key factors
- Education may influence men and here is the UK MHRA certified facility which
women’s desired family size is enabling us to register products not only
- Unmet need for family planning on Asia but in CIS countries, UK, Europe and
can help identify where greater it seems the door is open to the markets we
pill, resource investments are needed could only dream of. We dream big and we
- Married and unmarried women’s work hard to achieve it. The management is
reasons for not using determined to top the list of exporting
contraception vary by age companies not locally but globally through
- Method types remain limited, even proper planning and utilization. Adding to
as contraceptive use increases that, the government support has been
Where we stand? encouraging so far as the pharmaceutical
Renata Limited as we all know has been export might overtake the garments export
leading the local industry for some good by 2025. We believe that Renata can not
amount of time and we will fight to keep only establish its presence in the global
it that way. What has changed recently is reproductive healthcare sector, but, also
our global presence in the reproductive that we can change the lives of billions of
health care sector. Our partnerships with people worldwide.
Marie Stopes International, Population
MAXPRO Star Region Award
Getting recognition for the work is always inspiring. To encourage the
effort and the achievement of the sales team, recently three Regions
got rewarded as “MAXPRO Star Region Award - 2018.
Regional Heads - Mr. Abu Yousuf Rana [Tangail Region], Mr. Md.
Shakawat Hossain [Mymensingh Region] & Mr. A.B.M. Ahsanul Hoque
[Barishal Region] have received “MAXPRO Star Region Award - 2018”
from Mr. Kaiser Kabir, CEO & Managing Director of Renata Limited for
their huge achievement.
NEW PRODUCTs
Black seed is a plant. People have used it
seed to make medicine for over 2000 years.
It was even discovered in the tomb of the
Egyptian King Tut.
This oil is popular due to its extremely
healthy benefits both from both religious
and scientific perspectives. Unfortunately,
it has some characteristic side effects too
(flatulence, heartburn, stomach upset,
unpleasant tastes, belching etc.) if it is
taken raw. To overcome these unpleasant
effects, we have developed enteric coated
soft gel capsule Aliksir which is a unique
formulation worldwide.
Aliksir deals with: Reducing bad cholesterol
& increasing HDL, helping to control blood
pressure, helping to improve joint health,
Helpin g to control blood sugar level in
diabetes, improving coughing, wheezing
and lung function in people with asthma.
PULMINO
Pulmino 400mg tablet (Doxofylline 400mg)
was launched in March 2019 which is for
the treatment of Asthma, COPD and Acute
Bronchospasm. Pulmino is manufactured
with FLUIDBED Processor technology. The
benefts of Pulmino is: Porosity of granules
is very high, Faster disintegration, 100%
dissolution rate, No chance of Cross-
Contamination.
GLINTA
Glinta is used in the treatment of type 2
diabetes mellitus to improve glycemic
control in adults. It can be used along with
diet and exercise and sometimes with
other medications to lower blood sugar
levels in patients with type 2 diabetes
(condition in which blood sugar is too high
because the body does not produce or use
insulin normally).
BE A PART O F
RE NAT A INS IG HT
Ten threats to global health in 2019
We are looking for contributions from The world is facing multiple health challenges. These range from outbreaks gonorrhoea, and salmonellosis.
of vaccine-preventable diseases like measles and diphtheria, increasing Ebola and other high-threat pathogens
members of the Renata family to make
reports of drug-resistant pathogens, growing rates of obesity and physical In 2018, the Democratic Republic of the Congo saw two separate Ebola
this newsletter more interactive.
inactivity to the health impacts of environmental pollution and climate outbreaks, both of which spread to cities of more than 1 million
Keeping that in mind we anticipate people.This shows that the context in which an epidemic of a high-
change and multiple humanitarian crises. Here are 10 of the many issues
more write-ups from the employees of that will demand attention from World Health Organisation (WHO) and threat pathogen like Ebola erupts is critical.

Renata Limited. Last but not the least health partners in 2019. Weak primary health care

we would like to give special thanks to
those who have given us various inputs
to make this issue interesting. You can
email your write-ups to-
anupom.chowdhury@renata-ltd.com
RBT 2 019
Renata badminton Tournament is one
of the most anticipated events for the
Renata family members. The champion
teams of RBT 2019 are: Team 01 [Ms.
Air pollution and climate change
Microscopic pollutants in the air can penetrate respiratory and circulatory
systems, damaging the lungs, heart and brain, killing 7 million people
prematurely every year from diseases such as cancer, stroke, heart and
lung disease. Around 90% of these deaths are in low- and middle-income
countries, with high volumes of emissions from industry, transport and
agriculture, as well as dirty cookstoves and fuels in homes.
Non-communicable diseases
Non-communicable diseases, such as diabetes, cancer and heart disease,
are collectively responsible for over 70% of all deaths worldwide, or 41
million people. The rise of these diseases has been driven by five major risk
factors: tobacco use, physical inactivity, the harmful use of alcohol,
unhealthy diets and air pollution.
Global influenza pandemic
The world will face another influenza pandemic – the only thing we do not
know is when it will hit and how severe it will be. Global defences are only
as effective as the weakest link in any country's health emergency
preparedness and response system.
Fragile and vulnerable settings
Fragile settings exist in almost all regions of the world, and these are where
half of the key targets in the sustainable development goals, including on
Primary health care is usually the first point of contact people have with
their health care system, and ideally should provide comprehensive,
affordable, community-based care throughout life. Yet many countries
do not have adequate primary health care facilities.
Vaccine hesitancy
Vaccine hesitancy – the reluctance or refusal to vaccinate despite the
availability of vaccines – threatens to reverse progress made in tackling
vaccine-preventable diseases. Vaccination is one of the most cost-
effective ways of avoiding disease – it currently prevents 2-3 million
deaths a year, and a further 1.5 million could be avoided if global
coverage of vaccinations improved.
Dengue
Dengue, a mosquito-borne disease that causes flu-like symptoms and
can be lethal and kill up to 20% of those with severe dengue, has been
a growing threat for decades. Now, its season in these countries is
lengthening significantly (in 2018, Bangladesh saw the highest number
of deaths in almost two decades).
HIV
The progress made against HIV has been enormous in terms of getting
people tested, providing them with antiretrovirals, and providing
access to preventive measures such as a pre-exposure prophylaxis

Shuktara Jahan & Ms. Sthiti child and maternal health, remains unmet. (PrEP, which is when people at risk of HIV take antiretrovirals to prevent
Chakraborty Tuli] In the female Antimicrobial resistance infection). Since the beginning of the epidemic about 35 million people
category and Team 13 [Mr. Md. Masud Antimicrobial resistance – the ability of bacteria, parasites, viruses and have died.
Rana Bulbul & Dr. Amirul Islam] in the fungi to resist medicines – threatens to send us back to a time when we Source: World Health organization
male category. The male team has been were unable to easily treat infections such as pneumonia, tuberculosis,
crowned Champion for the third time in
a row in the male category. Employee Health Awareness
Employee’s wellbeing is one of the major priorities of Renata Limited.
Off Topic:
However, the wellbeing of people’s health falls into risk for so many causes.
1. My memory has gotten so bad
Osteoporosis is one of those causes which considered as a silent killer of
it has actually caused me to lose
human health. Over 32.5 million people suffer from Bone Decay especially
my job. I’m still employed. I just
women in our country and most of them is unaware of being affected by such
can’t remember where......
diseases. In line with that as a part of our Employee Health Awareness
program Renata arranged a Social Awareness Campaign on Bone Health
checkup at Renata Limited Head office premises. In this campaign there was
2. A positive attitude may not
conducted a bone scanning (free of cost) through experienced nutritionists solve all your problems, but it
and counseling was provided based on report generated from bone will annoy enough people to
scanning. The session was a very good one which helped to create awareness make it worth the effort…
about this matter among our employees.

Renata Insight Issue 09 July 2019

Editorial Committee: Corporate Headquarters

Plot # 1, Milk Vita Road,
Mr. Anupom Chowdhury, Senior Assistant Manager-HR Section # 7, Mirpur,
Mr. Syed Saheeb Ahmed, Assistant Manager-HR Dhaka- 1216
Ms. Nisbat Anwar, Head of Human Resources Bangladesh
www.renata-ltd.com
Follow us www.facebook.com/RenataLimited